Disability Benefit Period

Disability benefit period is a feature of disability insurance that determines how long benefits will be paid to the policyholder in the event of a qualifying disability. The benefit period starts after the waiting period (or elimination period) has been satisfied, and it specifies the length of time that the policyholder will receive benefit payments.  

The benefit period can range from several months to several years, depending on the policy and the specific needs of the policyholder. Longer benefit periods typically have higher premiums. Some common benefit period options include:

  • 2-year benefit period: This is a common option for short-term disability insurance policies. Benefit payments would continue for up to 2 years after the waiting period has been satisfied.

  • 5-year benefit period: This option provides benefit payments for up to 5 years after the waiting period has been satisfied.

  • To age 65 benefit period: This option provides benefit payments until the policyholder reaches age 65, as long as they continue to meet the definition of disability.

  • Lifetime benefit period: This option provides benefit payments for the lifetime of the policyholder, as long as they continue to meet the definition of disability.

The benefit period is an important factor to consider when purchasing disability insurance, as it can greatly impact the level of protection and financial security provided to the policyholder in the event of a disability.

Next Up

According to Mployer Insights’ 2026 analysis of 76,000+ employer benefit plans, disability insurance remains a major market differentiator, with only 41% of U.S. employers offering short-term disability (STD) and 38% offering long-term disability (LTD). While 60% salary replacement serves as the national standard across both benefit types, standard plan designs disproportionately expose higher earners due to median benefit caps of $1,602/week for STD and $8,273/month for LTD. Furthermore, alignment between STD benefit durations (median 26 weeks) and LTD elimination periods (68% at 90 days) remains a critical area for plan structure optimization.
Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.